July 13, 2018 -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. However, not all products containing valsartan are being recalled. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured.
The FDA’s review is ongoing and has included investigating the levels of NDMA in the recalled products, assessing the possible effect on patients who have been taking them and what measures can be taken to reduce or eliminate the impurity from future batches produced by the company.
“The FDA is committed to maintaining our gold standard for safety and efficacy. That includes our efforts to ensure the quality of drugs and the safe manner in which they’re manufactured,” said FDA Commissioner Scott Gottlieb, M.D. “When we identify lapses in the quality of drugs and problems with their manufacturing that have the potential to create risks to patients, we’re committed to taking swift action to alert the public and help facilitate the removal of the products from the market. As we seek the removal of certain drug products today, our drug shortages team is also working hard to ensure patients’ therapeutic needs are met in the United States with an adequate supply of unaffected medications.”
VALSARTAN Why Weren't We Warned? - YouTube
July 13, 2018 -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products cont...
FDA extend Recall of Blood Pressure Valsartan Drug causing ...
The Food and Drug Administration has extended the review of a blood pressure Valsartan drug. https://goo.gl/s2Y8Nm. ... VALSARTAN Why Weren't We Warned?
Valsartan News Videos - The Las Vegas Journal | LVJournal.com
National News FDA recalls blood pressure medication that could cause cancer[2.9K views]VALSARTAN Why Weren't We Warned?[520 views]Valsartán: estos son los medi
Diovan - YouTube
Diovan or valsartan treats high blood pressure. In the category of ARBs or angiotensin receptor blockers, ... VALSARTAN Why Weren't We Warned?
Valsartan Videos - by nrjournal.com
VALSARTAN Why Weren't We Warned? Penelope Lopez. Jul 17th 2018 26 views . 02:28 FDA Recalls Some Valsartan Drugs Due to Impurity Top Trends. Jul 17th 2018 5 views .
FDA recalls heart medications over cancer concerns Free ...
"We have carefully assessed the valsartan-containing medications sold in the United States, and we've found that the valsartan sold ... VALSARTAN Why Weren't We Warned?
PENELOPE LOPEZ (@PENNYLOPEZ973) | Twitter
VALSARTAN Why Weren't We Warned?: http:// youtu.be/bTm2p6uwDAg?a via @YouTube. ... why they be telling me I can wear that outfit and look good in it?
FDA recalls common heart drug over cancer concerns ...
“We have carefully assessed the valsartan-containing ... me in.' Fire officials warned that the blaze would ... whose boundaries also weren't formally ...